Stephen John Callister

Chroma Therapeutics Ltd. engages in the discovery and development of therapies for the treatment of cancer and inflammation. It focuses on the discovery and development of novel small molecule drugs based upon chromatin biology and novel cell accumulation approaches. The firm uses chromatin biology, drug accumulation approaches to discover and develop cancer, inflammation treatments and small molecule drugs. The company was founded by David Allis, Alan Hornsby Davidson, Alan Hastings Drummond, Anthony Kouzarides and Paul Workman in September 2001 and is headquartered in Abingdon, the United Kingdom.

Sphere Fluidics Ltd. develops technology platform for single cell analysis and characterization. Its products include Picodroplet single cell assay and isolation system, Cyto-Mine, ESI-Mine, Pico-Break, Pico-Glide, Pico-Surf, and Pico-Gen Picodroplet formation chips. It provides technology and expertise for research projects, technology development collaborations, and discovery partnerships. The company was founded by Christopher Abell and Wilhelmus Theodorus Stefanus Huck in 2010 and is headquartered in Cambridge, the United Kingdom.

Ventus Medical Ltd. develops novel inhalation and NRT smoking cessation technologies. The company is based in Liverpool, UK. The British company was founded in 2014 by David Lawson, Mark Dignum.

Pheno Therapeutics Ltd. operates as a biotechnology company. The firm develops remyelinating therapies for the unmet need for a neuroprotective therapy for multiple sclerosis. The company was founded on October 31, 2018 and is headquartered in Edinburgh, the United Kingdom.

Rappta Therapeutics Oy operates as a biopharmaceutical company. It develops anti-cancer drugs activating protein phosphatase 2A. The company was founded by Goutham Narla and Mikko Lauri Sampsa Mannerkoski on March 20, 2019 and is headquartered in Helsinki, Finland.

Alpha Anomeric SAS Develops genetic medicines for severe neuromuscular diseases. The company is headquartered in Paris, France.

Aleta Biotherapeutics, Inc. engages in the immuno-oncology service that focuses on transforming cellular therapeutics. It allows broad spectrum of cancer indication to be targeted including currently intractable solid tumors. The company was founded by Paul Rennert and Roy Lobb and is headquartered in Natick, MA.

Tridek-One Therapeutics SAS is a French private biotechnology company founded in 2018. The company is based in Paris, France. Tridek-One's scientific founders at INSERM conducted groundbreaking research on the role of CD31 in the modulation of the immune response, which forms the basis of the company's work. The company was founded in 2019 by Giuseppina Caligiuri, Antonino Nicoletti, and the CEO is Laurence de Schoulepnikoff.

Performance Electronics Ltd. designs and manufactures embedded electronic control systems. The private company is based in Cincinnati, OH.

Richmond Housing Partnership Ltd. operates as a non-profit organization which provides affordable housing. It offers housing for rent, principally for individuals and families who are unable to rent or buy on the open market, and providing supported housing for people who need additional housing related support. The organization was founded in 2000 and is headquartered in Teddington, the United Kingdom.

Student Loans Co. Ltd. provides financial support services for people studying at universities and colleges throughout. The company is based in Glasgow, UK. The British company is ultimately controlled by the Government of United Kingdom. The company was founded in 1989. Chris Larmer has been the CEO of the company since 2021.

Part of MWB Group Holdings Plc, O2 is a British company that offers a non-carbonated, keto-friendly recovery drink blended with oxygenated water and electrolytes to help athletes recover faster without compromising their health. The company is based in Marylebone, UK. O2 aims to make recovery more accessible, enjoyable, and convenient for athletes who work out like elite athletes but do not take the time to recover like the pros. The recovery drink was developed by a physician and a CrossFit trainer to help athletes spend less time recuperating and more time accomplishing their goals. For more information, visit drinko2.com and follow @drinko2recovery on Instagram.

The Local Data Co. Ltd. delivers database retail intelligence for desktops. The firm provides services to retail and leisure operators, investors and landlords, and local government, councils and bids sectors. The company was founded by Barnaby Oswald and Toby Robertson in 2003 and is headquartered in London, the United Kingdom.

Subsea Asset Location Technologies Ltd. provides bronze, silver, gold, and platinum sonar bells. It serves military, oil and gas, off-shore power cable, off-shore wind farm, sports, and fishing net markets, as well as subsea cable markets for telecoms and data. The company was founded in February 2008 and is headquartered in Dorset, the United Kingdom.

Aurix Ltd. engages in the provision of phonetic speech analytics technology solutions. The company is headquartered in London, the United Kingdom.

iCore Ltd. provides management services.

British Telecom Plc provides telecommunication services. It offers broadband, phone lines, mobile phones, and IT services. The company offers telecom products and services for commercial purpose. British telecom is headquartered in London, UK

Innovate UK promotes, supports and invests in technology research, development, and commercialization. The firm provides access to information about the funding and support opportunities through a range of channels. The company was founded on July 1, 2007 and is headquartered in Swindon, the United Kingdom.

BT Exact provides research and technology to telecommunications industry. The company is headquartered in Ipswich, UK

Foresight Group LLP (Foresight Group) is a private equity subsidiary of Foresight Group CI Ltd founded in 1984 by Bernard William Fairman. The firm is headquartered in London.

IBIS Media VCT 1 Plc acts as venture capital fund which invests in smaller unquoted, AIM listed & OFEX traded media companies located in the UK. The investment criteria include sustainable business model, competitive advantage, strong management teams and organic revenue growth potential. It provides financing for acquisitions, MBOs, MBIs, Pre-IPO, and expansion stage capital requirements. The company was founded on December 21, 2005 and is headquartered in London, the United Kingdom.

Amphista Therapeutics Ltd. is a biopharmaceutical company based in Biocity Glasgow, UK. The British company is focused on creating first-in-class therapeutics that selectively and efficiently degrade and remove disease-causing proteins using targeted protein degradation (TPD). The company's pipeline of novel small molecules is focused on challenging diseases, including cancer. Amphista is a spin-out of Professor Alessio Ciulli's labs at the University of Dundee and is funded by leading life science investors, including Advent Life Sciences, the European Investment Fund, the Scottish Investment Bank, and Biomotiv. The CEO of the company is Nicola Thompson.

F2G Ltd. provides novel drugs for the treatment of life-threatening systemic fungal diseases. It primarily focuses on developing an F3 series of anti mould compound, which is an antifungal agent that acts through a mechanism different from marketed drugs. The company was founded in 1998 and is headquartered in Manchester, the United Kingdom.

Novartis Venture Fund provides early stage venture capital to companies in Europe, North America and Asia. The fund's focus is on the development of novel therapeutics and platforms, therefore it focuses on such sectors as Biotechnology and Biopharma. The fund makes seed and early stage investments ranging up to USD 30 million per company over its life. The fund makes follow-on and co-investments.

Jazz Pharmaceuticals UK Ltd. is pharmaceutical company focused on in-licensing, developing and marketing late-stage oncology, oncology supportive care and critical care products. The company was founded in 2006 and is headquartered in Oxford, United Kingdom.

Celldex Research Corp. engages in provision of biological research and development. The company is headquartered in Phillipsburg, NJ.

Thiakis Ltd. develops hormone-based treatments for obesity and other metabolic diseases. It focuses to commercialize an effective anti-obesity treatment based on a peptide hormone called oxyntomodulin. The company was founded in 2004 by Steve Bloom and John Burt and is headquartered in Sandwich, the United Kingdom.

Avila Therapeutics, Inc. researches and develops covalent drugs. The company was founded in 2007 and is headquartered in Summit, NJ.